英力股份(300956.SZ):主要產品爲筆記本電腦結構件及相關精密模具,用於聯想等品牌的包括AI PC在內的各種筆記本電腦中
格隆匯2月20日丨英力股份(300956.SZ)在投資者互動平臺表示,公司主要產品爲筆記本電腦結構件及相關精密模具,用於聯想等品牌的包括AI PC在內的各種筆記本電腦中。2025年2月5日,聯想對外披露:其個人智能體“小天”已接入DeepSeek,爲用戶帶來更加智能、便捷的AI交互體驗。個人智能體“小天”是聯想在去年4月發佈的業內首款端側個人智能體,被率先內嵌於聯想AI PC之中,目前已經拓展至聯想的AI手機、AI平板等AI終端。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.